



Cerebellar atrophy is frequently 
associated with non-paraneoplastic 
sensory neuronopathy
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ABSTRACT
Sensory neuronopathies (SN) are peripheral nervous system disorders associated with 
degeneration of dorsal root ganglion neurons. Despite the evidence of a defective 
proprioceptive sensory input in SN, the prominent gait and truncal ataxia raises the 
question of a concomitant involvement of the cerebellum. Objective: To evaluate 
cerebellar atrophy in SN. Method: We analyzed MRI-based volumetry of anterior lobe 
(paleocerebellum) and total cerebellum in patients with non-paraneoplastic chronic SN 
and compared to age- and gender-matched controls. Results: Cerebellum and anterior 
lobe MRI volumetry were performed in 20 patients and nine controls. Mean anterior lobe 
and cerebellar volume were not statistically different. Three patients (15%), however, 
had an abnormal anterior lobe and cerebellar volume index (values outside 2.5 standard 
deviations). One of them also had a specific atrophy of the anterior lobe. All these 
patients had infectious or dysimmune associated SN. Conclusion: Cerebellar atrophy is 
infrequently associated with SN, but can be found in some patients with SN related to 
infectious or immune mediated conditions. It can be more prominent in the anterior lobe 
and may contribute to the ataxia seen in these patients.
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Atrofia cerebelar não é um achado frequente em pacientes com neuronopatia sensi­
tiva não paraneoplasica
RESUMO
Neuronopatias sensitivas (NS) são distúrbios do sistema nervoso periférico associados 
com a degeneração dos neurônios do gânglio da raiz dorsal. Apesar da evidência de 
um defeito das aferências proprioceptivas, a ataxia proeminente da marcha e do tronco 
levanta a questão de uma participação concomitante do cerebelo. Objetivo: Avaliar a 
atrofia cerebelar nas NS. Método: Foi analisada volumetria pela ressonância magnética 
do cerebelo total e do lobo anterior (paleocerebelo) em pacientes com NS crônica 
não-paraneoplásica e comparada a controles com idades e sexos correspondentes. 
Resultados: A volumetria do cerebelo e lobo anterior foi realizada em 20 pacientes e nove 
controles. As médias do volume cerebelar e do lobo anterior não foram estatisticamente 
diferentes. Três pacientes, entretanto, tiveram um valor anormal do índice de volume 
cerebelar e do lobo anterior (valores fora de 2,5 desvios-padrão). Um deles tinha inclusive 
uma atrofia específica do lobo anterior. Todos esses pacientes tinham NS associada a 
doenças infecciosas ou disimunes. Conclusão: Atrofia cerebelar é raramente associada 
com SN, mas pode ser encontrada em alguns pacientes com NS relacionada com doenças 
infecciosas ou imunológicas. Esta atrofia pode ser mais proeminente no lobo anterior e 
pode contribuir para a ataxia observada nestes pacientes.
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Sensory neuronopathies (SN) are peripheral nervous 
system disorders associated with degeneration of dorsal 
root ganglion (DRG) neurons. Impairment of large neu-
rons leads to sensory gait ataxia, proprioceptive sen-
sory loss and widespread areflexia, while degeneration 
of small and medium size neurons causes sensory symp-
toms such as burning and allodynia1. Despite the evi-
dence of a defective proprioceptive sensory input in SN, 
the prominent gait and truncal ataxia, remarkable even 
with opened eyes, raises the question of a concomitant 
involvement of the cerebellum or more specifically, the 
paleocerebellum2,3. Furthermore, cerebellar peduncles 
and tracts other than posterior columns were involved 
in a patient with Sjögren syndrome associated SN4.
To evaluate this question we analyzed MRI-based vol-
umetry of anterior lobe (paleocerebellum) and total cere-
bellum in patients with non-paraneoplastic chronic ac-




We retrospectively reviewed clinical, electrophysio-
logical and cervical spine MRI data of patients referred 
to our neuromuscular disease outpatient clinic in the 
last eight years for predominantly sensory disturbances, 
looking for patients with SN. 
Twenty patients were enrolled fulfilling SN criteria 
which comprised: clinical - sensory ataxia, focal sensory 
signs, and normal muscle strength; and electrophysio-
logical features - widespread decrease, involving both 
upper and lower limb nerves, in sensory nerve action 
potential (SNAP) amplitudes, normal sensory and motor 
conduction velocities (CV) and normal needle electro-
myography (EMG). All patients underwent an addi-
tional complete neurological evaluation, after giving in-
formed consent. Sensory ataxia was scored according to 
the functional staging of Friedreich’s Ataxia Rating Scale 
(FARS)5,6. Neither patients with molecular genetic confir-
mation of Friedreich ataxia nor individuals with familial 
history of neurological disease were included in the study. 
We performed radiological, hematological, biochemical, 
and serological screening to investigate malignancies, 
dysimmune, infectious, metabolic and vitamin disorders. 
None of our patients had a past history of chronic al-
cohol intake or phenytoin administration. More detailed 
methodological aspects are described elsewhere7. This 
study was approved by the ethics committee of the fac-
ulty of medical sciences of the University of Campinas 
(Campinas, Brazil). All subjects that participated in 
the present study provided signed informed consent.
MRI was performed on a 2.0 T scanner (Elscint 
Prestige, Haifa, Israel). Our protocol consisted of cra-
nial sagittal T1 spin-echo (3mm thick; 0% gap; flip 
angle=180°; repetition time=550 ms; echo time=12 ms; 
matrix=270×200; field of view=24×24cm), and sag-
ittal T2 (3 mm thick; 0% gap; flip angle=110°; repetition 
time=4900 ms; echo time=128 ms; matrix=320×252; 
field of view=24×24 cm). Visual analysis of MRI results 
was systematically performed by one of us (A.D.), blinded 
to the clinical data. Volumetric measurements of the cer-
ebellums of all patients were made through a semiau-
tomatic segmentation software (neuroline), previously 
validated, using sagittal T1 images8. The cerebellum was 
manually outlined on sagittal slices (Fig 1A). The anterior 
lobe of the cerebellum was outlined in 10 sagittal slices, 
five to the left of cerebral aqueduct and another five to 
the right. Its limits were the primary fissure (posterior) 
and the superior medullary velum (anterior) (Fig 1B). 
The cerebellums and anterior lobes of nine healthy 
volunteers measured with the same criteria were spe-
cifically obtained for this study and constituted a con-
trol group. Anterior lobe volume (ALV) and cerebellar 
volume (CEV) were corrected for intracranial volume 
as follows: Normalized structure volume = (patients’ 
structure volume × mean cerebral volume of controls)/
patients’ cerebral volume. Looking for relative atrophy 
we also defined the following indexes: RALV and RCEV, 
calculated as ALV and CEV divided by the total brain 
volume respectively. A third index created was ALV/
CEV, looking for specific atrophy of anterior lobe. Values 
smaller than 2.5 SDs (95% confidence interval) of the 
control group means were considered abnormal.
Statistical analyses
Basic demographic, laboratorial, electrophysiolog-
ical and neuroimaging profile of patients was represented 
by descriptive statistics. Comparison of means was per-
formed with Mann-Whitney U tests (two independent 
groups) or Kruskall-Wallis (multigroup comparison). All 
correlations were made with linear regression (Spearman 
Fig 1. Cerebellum and anterior lobe segmentation. The cere-
bellum was manually outlined on sagittal slices [A]. The anterior 
lobe of the cerebellum was also outlined in sagittal slices [B]. Its 
limits were the primary fissure (PF) posteriorly, and the superior 
medullary velum (SMV) anteriorly.
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coefficient). Statistical analyses were performed with 
STATISTICA software (StatSoft, Inc.; Tulsa, OK, USA). 
The level of significance was established as p<0.05.
RESULTS
Clinical and laboratorial findings
Neurological evaluation took place 98 months (range: 
30-175) after disease onset. Mean age at evaluation was 
50.95 years (range: 20-80). Twelve were female and eight 
male. Mean age at disease onset was 43 years (range: 
17-75), 80% being between 38 and 55 years. Functional 
staging for ataxia was 3.45 (range: 2-5) and three patients 
(15%) were confined to a wheelchair. SN was associated 
with dysimmune conditions in six patients: three with 
Sjögren’s syndrome, one with autoimmune active hepa-
titis, one with monoclonal gammopathy of undetermined 
significance, and one with unclassified dysimmune syn-
drome (positive antinuclear antibody (1:320) and elevated 
sedimentation rate (45 mm/h) but no other findings). SN 
was related to active hepatitis C in one patient, who also 
tested positive for cryoglobulins, to vitamin B12 deficiency 
in one patient, and to organophosphate intoxication in 
another. The remaining eleven patients were considered 
as idiopathic SN (Table). Investigation for malignancies 
was repeatedly normal. Nine healthy subjects served as 
a control group. Mean age was 44.77 years (range: 25-
59, p=0.19). Two were male and seven female (p=0.35). 
Cerebellum and anterior lobe 
(Paleocerebellum) MRI findings 
Cerebellum and anterior lobe MRI volumetry were 
performed in all patients, 97.85 months after disease onset 
(range 30-175 months). Volumetric measurements (mean 
CEV, ALV, RALV, RCEV, and ALV/CEV) were not sta-
tistically different between patients and controls (Fig 2). 
Three patients (2, 9 and 10), however, had abnormal 
RALV and RCEV. One of them (10) also had an abnormal 
ALV/CEV (Fig 3) and ALV.
There was no significant correlation between volu-
metric measures and clinical parameters (age at disease 
onset, disease duration and functional staging of FARS). 
Groups of SN associated disorders (i.e. dysimmune and 
idiopathic) showed no difference regarding those vol-
umetric measures. Nonetheless, all patients with ab-














































Fig 2. Box-whisker plots of volumetric measures. Mean relative anterior lobe volume (RALV), relative cerebellar volume (RCEV), and 











1 20/F 17 2 Nl Idiopathic
2 49/F 38 5 + UDS
3 47/M 43 5 + Idiopathic
4 53/M 38 4 + Idiopathic
5 46/F 35 4 + Sjögren
6 65/F 62 4 Nl Sjögren
7 54/F 43 4 + Idiopathic
8 53/M 39 3 Nl Idiopathic
9 80/F 75 4 + Sjögren
10 53/M 42 2 ND Hepatitis C
11 59/F 46 5 + B12 deficiency
12 58/M 55 2 ND Idiopathic
13 49/M 42 3 + OP intoxication
14 47/F 44 2 Nl Idiopathic
15 43/M 40 3 + Idiopathic
16 49/M 41 4 + Idiopathic
17 43/F 34 3 + Idiopathic
18 51/F 47 2 + Idiopathic
19 61/F 52 4 + MGUS
20 39/F 28 4 + AIH
+: posterior columns hyperintensisty on cervical spine MRI; AIH: 
autoimmune hepatitis; ALV/CEV: anterior lobe volume divided by 
cerebellar volume; CS MRI: cervical spine MRI; MGUS: monoclonal 
gammopathy of undetermined significance; ND: not done; Nl: normal; 
OP: organophosphate; RALV: relative anterior lobe volume; RCEV: relative 
cerebellar volume; UDS: unclassified dysimmune syndrome.
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associated SN, compared to four of those with normal 
volumetric parameters (p=0.01). Patients with abnormal 
volumetric measures were similar to others regarding 
clinical parameters and cervical spine MRI (p>0.25).
DISCUSSION
Impairment of DRG large neurons causes gait ataxia, 
proprioceptive sensory loss and widespread muscle 
stretch areflexia1,9,10. In many patients, however, there is 
a disproportionate gait and truncal ataxia in comparison 
to limb incoordination, which is also remarkable with 
preserved visual input, resembling a cerebellar dysfunc-
tion. Indeed, involvement of both DRG and cerebellum 
has been described in paraneoplastic disorders, and, fur-
thermore, serum antibodies directed against a shared ep-
itope in Purkinje cells and DRG neurons have been also 
reported in patients with SN without malignancies11,12. 
These findings may explain immune mediated concomi-
tant dysfunction of cerebellum and DRG cells in patients 
with SN. Moreover, recent evidence also showed prox-
imal involvement of the mesencephalon, medial lem-
niscus and cerebellar peduncles in a patient with Sjögren 
syndrome associated SN. This finding raised the question 
of a possible participation of other pathways carrying un-
conscious proprioceptive information, such as the spino-
cerebellar tracts, in SN phenotype4. 
This was a preliminary study that presents some limi-
tations such as a small control group and a simplified ac-
quisition protocol. Despite this, we are able to identify 
cerebellar atrophy in three patients (15%) with infectious 
or dysimmune SN. In one of the patients, the atrophy 
was even more prominent in the anterior lobe. This lobe, 
corresponding approximately to the paleocerebellum, re-
ceives afferent connections mainly from the anterior spi-
nocerebellar tract through superior cerebellar peduncle, 
and is involved in locomotion and posture13. Damage 
of such tracts could lead to shrinkage of afferent cere-
bellar regions. Indeed, degeneration of DRG neurons and 
spinal cord tracts play a role in the cerebellar and dorsal 
brainstem atrophy found in Friedreich’s ataxia14. Alter-
natively, the associated primary disease may lead directly 
to both cerebellar and DRG dysfunction. In dysimmune 
conditions such as Sjögren’s syndrome, for example, the 
immune mediated damage has been implicated as the 
underlying mechanism for cerebellar ataxia and sensory 
neuropathies including SN1,15. Although our patient (10) 
did not have sicca symptoms he did present cryoglob-
ulinemia. Furthermore, none of the patients with idio-
pathic SN had cerebellar atrophy. Therefore, an immune 
mediated degeneration of both DRG and cerebellum is 
a likely explanation, as has been previously described12.
We conclude that cerebellar atrophy is infrequently 
associated with SN, but can be found in rare patients 
with SN related to infectious or immune mediated con-
ditions. It can be more prominent in the anterior lobe 
and may contribute to the remarkable gait and truncal 
ataxia seen in these patients, but further data is needed 
to better investigate this association. Concomitant cere-
bellar and DRG dysfunction should prompt dysimmune 
and hepatitis C investigation.
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